Insulin Aspart

NovoLog · Fiasp

Other GLP-1 SubQ FDA/EMA Label

Half-life

1.5 hr

Time to Peak

1 hr

Steady State

~1 days

Bioavailability

55%

Dose Range

1–100 units

Frequency

with meals

Overview

Rapid-acting insulin analogue. Similar profile to lispro. Fiasp is the ultra-rapid formulation with niacinamide for faster initial absorption.

Mechanism of Action

Recombinant insulin analogue with aspartic acid substitution at B28, reducing hexamer formation and enabling rapid subcutaneous absorption.

Dosing Information

Route	Dose Range	Half-life	Tmax	Frequency
Subcutaneous (SubQ)	1–100 units	1.5 hr	1 hr	with meals, three times daily

Used in Regimens

Insulin Aspart is not currently part of any catalog regimen.

Data Sources

FDA Label NovoLog (insulin aspart) FDA Prescribing Information

Related Tools

Medication Level Plotter

See blood level curves for this compound

Dose Calculator

Calculate reconstitution and draw volumes

Split Dose Calculator

Divide your weekly dose into multiple injections

Track Insulin Aspart with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.